PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)

NCT05357846 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

422

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Esophageal Carcinoma
Esophageal Cancer
Oesophageal Cancer

Interventions

DRUG: Sintilimab
RADIATION: Preoperative radiotherapy
DRUG: Paclitaxel
DRUG: Cisplatin
PROCEDURE: esophagectomy

Sponsor

Sun Yat-sen University

Collaborators

[object Object]